Insulinoma: a case report of a successful resective surgery
DOI:
https://doi.org/10.24265/horizmed.2023.v23n4.10Keywords:
brain stem infarctions, HIV, toxoplasmosisAbstract
Insulinoma is a pancreatic neuroendocrine tumor that produces hyperinsulinism and causes a severe lowering of blood glucose levels with chronic symptoms such as fainting. It is more common in males and can occur at any age, either as
solitary or multiple neoplasms, the latter known to be part of the multiple endocrine neoplasia, type 1 (MEN 1) group. Insulinomas are rare and require resective surgery, with symptoms resolution being the marker of recovery. This article describes a case of insulinoma in a 51-year-old woman with a clinically typical presentation and signs and symptoms
of hyperinsulinism. Laboratory tests revealed increased insulin secretion, while magnetic resonance imaging showed features of insulinoma, where the pancreatic tumor could be seen. This case was treated by surgical resection of the pancreatic tumor during an exploratory laparotomy, using the enucleation technique, which is described in detail herein. There were no intraoperative or postoperative complications, i.e., the result was successful in terms of health recovery.
This surgical technique is used at Hospital Nacional Arzobispo Loayza in Lima, Peru, when facing cases such as the one described. This type of neoplasm is very uncommon, so it should be considered highly suspicious and, in this case, the images were essential for choosing the surgical resection. Other cases of insulinoma have been treated surgically at the Hospital; moreover at least one case of nesidioblastosis could not receive an adequate treatment.
Downloads
References
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829-37.
Bouslama K, Maghrebi H, Bedioui H, Bouslama K. L'insulinome pancreatique: approche diagnostique et modalites therapeutiques. J Afr Hepatol Gastroenterol. 2014;8:11-5.
Patel S, Narwari M, Parekh D, Shah V. Insulinoma: case report and review of diagnostic and treatment modalities. J Assoc Physicians India. 2013;61(6):423-6.
Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol. 2010;6(2):229-37.
Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711-9.
Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19(10):1727-33.
Sada A, Glasgow AE, Vella A, Thompson GB, McKenzie TJ, Habermann EB. Malignant insulinoma: a rare form of neuroendocrine tumor. World J Surg. 2020;44(7):2288-94.
Abboud B, Boujaoude J. Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol. 2008;14(5):657-65.
Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am. 1999;28(3):495-500.
Rostambeigi N, Thompson GB. What should be done in an operating room when an insulinoma cannot be found? ClinEndocrinol (Oxf). 2009;70(4):512-5.
Gramatica L, Herrera MF, Mercado-Luna A, Sierra M, Verasay G, Brunner. Videolaparoscopic resection of insulinomas: experience in two institutions. World J Surg. 2002;26(10):1297-300.
Christ E, Iacovazzo D, Korbonits M, Perren A. Insulinomatosis: new aspects. Endocr Relat Cancer. 2023;30(6):e220327.
Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194(6):761-4.
Pellegrino F, Granata V, Fusco R, Grassi F, Tafuto S, Perrucci L, et al. Diagnostic management of gastroenteropancreatic neuroendocrine neoplasms: technique optimization and tips and tricks for radiologists. Tomography. 2023;9(1):217-46.
Dravecka I, Lazurova I. Nesidioblastosis in adults. Neoplasma. 2014;61(3):252-6.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Luis Enrique Machicado Rivero
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).